Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 574
Clinical Trials 255
Immune Disorders Drugs 238
Cardiovascular Drugs 197
Drug Discovery 193
Pharmaceuticals 186
Infectious Diseases Drugs 173
Biopharmaceuticals 151
Central Nervous System Drugs 133
Endocrine and Metabolic Disorders Drugs 126
Musculoskeletal Disorders Drugs 106
Liver and Kidney Disorders Drugs 105
Leukemia Drugs 104
Hematological Drugs 96
Lymphoma Drugs 71
Dermatological Drugs 66
Brain Cancer Drugs 63
Diabetes Drugs 61
Skin Cancer Drugs 61
Gastrointestinal Drugs 52
Respiratory Drugs 51
Mental Disorders Drugs 47
Lung Cancer Drugs 46
Pharmaceutical Intermediates 45
Drug Delivery 41
Immunosuppressive Drugs 40
Pharmaceutical Manufacturing 38
Liver Cancer Drugs 37
Bladder Cancer Drugs 34
Infusions and Injectables 32
Analgesics 28
HIV/AIDS Drugs 27
Colon Cancer Drugs 25
Antibiotics 25
Kidney Cancer Drugs 24
Drugs by Therapeutic Area 23
Prostate Cancer Drugs 22
Cancer Vaccines 22
Schizophrenia Drugs 22
Ovarian Cancer Drugs 20
Pancreatic Cancer Drugs 20
Sexual and Reproductive Health Drugs 19
Breast Cancer Drugs 18
Urological Disorders Drugs 17
Cervical Cancer Drugs 16
Psoriasis Drugs 14
Thyroid Cancer Drugs 13
Biosimilars and Biosuperiors 12
Over the Counter (OTC) Drugs 11
Vaccines 11
Generic Drugs 10
Alzheimer's Disease Drugs 9
Company Reports 8
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 7
Addiction Disorders Drugs 4
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

3,009 Results (Page 6 of 151)
- Relevance
  Sort by

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

 Report
June 2023
174 Pages
Global

From

€5247EUR$5,500USD£4,467GBP

Megestrol Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
August 2023
110 Pages
Global

From

€3500EUR$3,930USD£3,084GBP

Top Selling Biologics Market, 2021-2030: Focus on Product Landscape Assessment, Ongoing Clinical Trials, Promotional Content Analysis, Other Life Cycle Management Strategies, Competition from Biosimilars, Annual Treatment Cost Comparison, Sales Evolution and Future Opportunity

 Report
April 2021
242 Pages
Global

From

€4578EUR$4,799USD£3,898GBP

toxoplasmosis Treatment Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4770EUR$5,000USD£4,061GBP

HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
November 2023
35 Pages
Global

From

€3520EUR$3,690USD£2,997GBP

NEED HELP FINDING THE RIGHT PRODUCT? Andrea will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Global Hepatitis B Therapeutics Market 2022-2026

 Report
April 2022
120 Pages
Global

From

€2385EUR$2,500USD£2,031GBP

Sexually Transmitted Diseases (STDs) Drug - Global Strategic Business Report

 Report
May 2024
196 Pages
Global

From

€5199EUR$5,450USD£4,427GBP

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
82 Pages
Global

From

€1908EUR$2,000USD£1,625GBP

Inflammatory bowel disease (IBD) Therapeutics Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
110 Pages
Global

From

€4531EUR$4,750USD£3,858GBP

Brain Hemorrhage - Pipeline Insight, 2024

 Clinical Trials
April 2024
75 Pages
Global

From

€1431EUR$1,500USD£1,218GBP

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020

 Drug Pipelines
August 2020
1285 Pages
Global

From

€2385EUR$2,500USD£2,031GBP

Global Endometrial Cancer Treatment Market by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy), Grade (Type I, Type II), End-User - Forecast 2024-2030

 Report
March 2024
199 Pages
Global

From

€3219EUR$3,374USD£2,741GBP

€3577EUR$3,749USD£3,045GBP

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

 Report
April 2020
536 Pages
Global

From

€4674EUR$4,899USD£3,979GBP

Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035

 Drug Pipelines
December 2022
30 Pages
Global

From

€2623EUR$2,750USD£2,234GBP

Global Ankylosing Spondylitis Market by Drug (Cimzia, Cosentyx, Enbrel), Type of Molecule (Biologics, Small Molecules), Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Forecast 2024-2030

 Report
March 2024
193 Pages
Global

From

€3219EUR$3,374USD£2,741GBP

€3577EUR$3,749USD£3,045GBP

Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
162 Pages
Global

From

€1908EUR$2,000USD£1,625GBP

United States Skin Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
90 Pages
United States

From

€3339EUR$3,500USD£2,843GBP

HIV Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4770EUR$5,000USD£4,061GBP

Bladder Cancer Therapeutics - Global Strategic Business Report

 Report
May 2024
283 Pages
Global

From

€5199EUR$5,450USD£4,427GBP

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4770EUR$5,000USD£4,061GBP

3,009 Results (Page 6 of 151)
- 1
- 4
- 5
- 6
- 7
- 8

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.